Submitted by Anonymous (not verified) on 6 June 2024 - 8:17
Human medicines European public assessment report (EPAR): Myocet liposomal (previously Myocet), doxorubicin, Date of authorisation: 13/07/2000, Revision: 25, Status: Authorised
Source: